Common Stock, Shares, Outstanding of ABVC BIOPHARMA, INC. from Q3 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Abvc Biopharma, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q3 2010 to Q3 2025.
  • Abvc Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 24.2M shares, a 90.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

ABVC BIOPHARMA, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 24.2M +11.5M +90.3% 30 Sep 2025 10-Q 03 Nov 2025
Q2 2025 19.5M +7.48M +62.1% 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 15.4M +4.68M +43.7% 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 13.9M +5.93M +74.7% 31 Dec 2024 10-Q 03 Nov 2025
Q3 2024 12.7M +7.89M +164% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 12.1M +8.74M +264% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 10.7M -22.4M -67.7% 31 Mar 2024 10-Q 17 May 2024
Q4 2023 7.94M +4.65M +142% 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 4.82M -27.8M -85.2% 30 Sep 2023 10-Q 15 Nov 2023
Q2 2023 3.31M -29M -89.8% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 33.1M +2.77M +9.15% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 3.29M -21.1M -86.5% 31 Dec 2022 10-K 13 Mar 2024
Q3 2022 32.6M +4.7M +16.8% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 32.3M +7.84M +32% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 30.3M +5.89M +24.1% 31 Mar 2022 10-Q 16 May 2022
Q4 2021 24.4M 0 0% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 27.9M +7.54M +37% 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 24.5M +4.98M +25.6% 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 24.4M +4.93M +25.3% 31 Mar 2021 10-Q 10 May 2021
Q4 2020 24.4M +4.94M +25.4% 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 20.4M +916K +4.7% 30 Sep 2020 10-Q 17 Nov 2020
Q2 2020 19.5M +1.37M +7.54% 30 Jun 2020 10-Q 14 Aug 2020
Q1 2020 19.5M +1.79M +10.1% 31 Mar 2020 10-Q 29 Jun 2020
Q4 2019 19.5M +7.59M +63.9% 31 Dec 2019 10-K 16 Mar 2021
Q3 2019 19.5M -194M -90.9% 30 Sep 2019 10-Q 18 Nov 2019
Q2 2019 18.1M -196M -91.5% 30 Jun 2019 10-Q 09 Aug 2019
Q1 2019 17.7M -196M -91.7% 31 Mar 2019 10-Q 28 May 2019
Q4 2018 11.9M -202M -94.4% 31 Dec 2018 10-K 15 May 2020
Q3 2018 214M +180K +0.08% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 214M +180K +0.08% 30 Jun 2018 10-Q 20 Aug 2018
Q1 2018 214M +180K +0.08% 31 Mar 2018 10-Q 15 May 2018
Q4 2017 214M +2.93M +1.39% 31 Dec 2017 10-K 15 Apr 2019
Q3 2017 214M +2.93M +1.39% 30 Sep 2017 10-KT 13 Apr 2018
Q2 2017 214M +4.39M +2.1% 30 Jun 2017 10-Q 19 Mar 2018
Q1 2017 214M +4.99M +2.39% 31 Mar 2017 10-Q/A 19 Mar 2018
Q4 2016 211M +145M +222% 31 Dec 2016 10-Q/A 19 Mar 2018
Q3 2016 211M +44.5M +26.8% 30 Sep 2016 10-Q 19 Mar 2018
Q2 2016 209M +155M +283% 30 Jun 2016 10-Q 22 Feb 2017
Q1 2016 209M +154M +282% 31 Mar 2016 10-Q 17 May 2016
Q4 2015 65.4M +10.8M +19.9% 31 Dec 2015 10-Q 23 Feb 2016
Q3 2015 166M +166M 30 Sep 2015 10-K/A 22 Sep 2017
Q2 2015 54.6M 0 0% 30 Jun 2015 10-Q 19 Aug 2015
Q1 2015 54.6M 0 0% 31 Mar 2015 10-Q 05 Jun 2015
Q4 2014 54.6M 0 0% 31 Dec 2014 10-Q 17 Apr 2015
Q3 2014 11.1K* -54.6M 30 Sep 2014 10-Q 23 Feb 2016
Q2 2014 54.6M 0 0% 30 Jun 2014 10-Q 17 Apr 2015
Q1 2014 54.6M 0 0% 31 Mar 2014 10-Q 17 Apr 2015
Q4 2013 54.6M 0 0% 31 Dec 2013 10-Q 17 Apr 2015
Q3 2013 54.6M +40.4M +286% 30 Sep 2013 10-Q 17 Apr 2015
Q2 2013 54.6M +53.2K +0.1% 30 Jun 2013 10-Q 16 Apr 2015
Q1 2013 54.6M +38.3M +234% 31 Mar 2013 10-Q 16 Apr 2015
Q4 2012 54.6M +38.3M +234% 31 Dec 2012 10-Q 16 Apr 2015
Q3 2012 14.2M 0 0% 30 Sep 2012 10-K 16 Apr 2015
Q2 2012 54.5M +43.9M +412% 30 Jun 2012 10-Q/A 20 Aug 2012
Q1 2012 16.3M 31 Mar 2012 10-Q 15 May 2012
Q4 2011 16.3M 31 Dec 2011 10-Q 21 Feb 2012
Q3 2011 14.2M -18.8M -57% 30 Sep 2011 10-K 15 Apr 2015
Q2 2011 10.7M 30 Jun 2011 10-Q/A 08 Sep 2011
Q3 2010 32.9M 30 Sep 2010 10-K/A 28 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.